Cargando…

Polymorphisms in LPL, CETP, and HL protect HIV-infected patients from atherogenic dyslipidemia in an allele-dose-dependent manner

INTRODUCTION: HIV-infected patients treated with Highly Active Antiretroviral Therapy (HAART) may be predisposed to hypertriglyceridemia, which gives rise to a highly atherogenic lipid profile known as atherogenic dyslipidemia (AD). We propose that genetic variability leaves some HIV-infected patien...

Descripción completa

Detalles Bibliográficos
Autores principales:	Echeverría, Patricia, Guardiola, Montse, González, Marta, Carles Vallvé, Joan, Puig, Jordi, Bonjoch, Anna, Clotet, Bonaventura, Ribalta, Josep, Negredo, Eugenia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	International AIDS Society 2014
Materias:	Poster Sessions – Abstract P025
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4224864/ https://www.ncbi.nlm.nih.gov/pubmed/25394064 http://dx.doi.org/10.7448/IAS.17.4.19557

Ejemplares similares

Association between lipid genetic and immunological status in chronically HIV-infected patients
por: Echeverría, Patricia, et al.
Publicado: (2014)

Évaluations externes de la qualité des trousses anticorps anti-SARS-CoV-2
por: Defer, Christine, et al.
Publicado: (2021)

Réactions cutanées post-vaccin COVID-19
por: Idrissi, Oumayma Kamal, et al.
Publicado: (2021)

PERFIL CLÍNICO‐EPIDEMIOLÓGICO DE CRIANÇAS E ADOLESCENTES COM DIAGNÓSTICO PARA O VÍRUS DE INFLUENZA INTERNADOS COMO SUSPEITA INICIAL DE COVID‐19 EM HOSPITAL DE REFERÊNCIA
por: Gonçalves, Ana Luíza Nogueira, et al.
Publicado: (2021)

COMORBIDADES PEDIÁTRICAS, RAÇA E FAIXA ETÁRIA EM COVID-19 NO BRASIL: UM ESTUDO COORTE RETROSPECTIVO
por: dos Santos, Ivan Lira, et al.
Publicado: (2022)

PERFIL DE RESISTÊNCIA DE PSEUDOMONAS AERUGINOSA EM UMA UNIDADE PÚBLICA MATERNO-INFANTIL NA PANDEMIA DA COVID-19
por: Vieira, Claudia Cristina Augusto Rodrigues, et al.
Publicado: (2022)

High Prevalence of Sarcopenia in HIV-Infected Individuals
por: Echeverría, Patricia, et al.
Publicado: (2018)

Association of CETP Gene Variants with Atherogenic Dyslipidemia Among Thai Patients Treated with Statin
por: Srisawasdi, Pornpen, et al.
Publicado: (2021)

Prospective Study to Assess Progression of Renal Markers after Interruption of Tenofovir due to Nephrotoxicity
por: Bonjoch, Anna, et al.
Publicado: (2016)

A randomized pilot trial to evaluate the benefit of the concomitant use of atorvastatin and Raltegravir on immunological markers in protease-inhibitor-treated subjects living with HIV
por: Negredo, Eugènia, et al.
Publicado: (2020)

Effets de la pandémie COVID-19 sur l’évolution de la lombalgie chronique
por: Ardhaoui, M., et al.
Publicado: (2022)

Sex-associated effect of CETP and LPL polymorphisms on postprandial lipids in familial hypercholesterolaemia
por: Anagnostopoulou, Katherine K, et al.
Publicado: (2009)

CETP/LPL/LIPC gene polymorphisms and susceptibility to age-related macular degeneration
por: Wang, Ya-Feng, et al.
Publicado: (2015)

Impact of protease inhibitors on the evolution of urinary markers: Subanalyses from an observational cross-sectional study
por: Bonjoch, Anna, et al.
Publicado: (2016)

APOE, CETP and LPL genes show strong association with lipid levels in Greek children()
por: Smart, M.C., et al.
Publicado: (2010)

Atherogenic dyslipidemia
por: Manjunath, C. N., et al.
Publicado: (2013)

Randomised Study to Assess the Efficacy and Safety of Once-Daily Etravirine-Based Regimen as a Switching Strategy in HIV-Infected Patients Receiving a Protease Inhibitor–Containing Regimen. Etraswitch Study
por: Echeverría, Patricia, et al.
Publicado: (2014)

Prevalence of Ischemic Heart Disease and Management of Coronary Risk in Daily Clinical Practice: Results from a Mediterranean Cohort of HIV-Infected Patients
por: Echeverría, Patricia, et al.
Publicado: (2014)

Polymorphisms in the LPL and CETP Genes and Haplotype in the ESR1 Gene Are Associated with Metabolic Syndrome in Women from Southwestern Mexico
por: Cahua-Pablo, José Ángel, et al.
Publicado: (2015)

Remote Health Monitoring in the Workplace for Early Detection of COVID-19 Cases during the COVID-19 Pandemic Using a Mobile Health Application: COVIDApp.
por: Echeverría, Patricia, et al.
Publicado: (2021)

Anacetrapib, a New CETP Inhibitor: The New Tool for the Management of Dyslipidemias?
por: Filippatos, Theodosios D., et al.
Publicado: (2017)

Randomized, crossover, double-blind, placebo-controlled trial to assess the lipid lowering effect of co-formulated TDF/FTC
por: Ramón Santos, José, et al.
Publicado: (2014)

Search for genetic factors predisposing to atherogenic dyslipidemia
por: Yip, Agustin G, et al.
Publicado: (2003)

Atherogenic Dyslipidemia: Cardiovascular Risk and Dietary Intervention
por: Musunuru, Kiran
Publicado: (2010)

Oxidative Stress, Atherogenic Dyslipidemia, and Cardiovascular Risk
por: Vekic, Jelena, et al.
Publicado: (2023)

Improving Assessment of Lipoprotein Profile in Type 1 Diabetes by 1H NMR Spectroscopy
por: Brugnara, Laura, et al.
Publicado: (2015)

Anti-PCSK9 antibodies inhibit pro-atherogenic mechanisms in APOE*3Leiden.CETP mice
por: Schuster, Susanne, et al.
Publicado: (2019)

Adherence and health beliefs in a psychoeducative intervention in naïve HIV-1-infected men: the PROADH study
por: Fumaz, C, et al.
Publicado: (2012)

A novel swine model for evaluation of dyslipidemia and atherosclerosis induced by human CETP overexpression
por: Chen, Tao, et al.
Publicado: (2017)

Adipocyte Triglyceride Turnover Is Independently Associated With Atherogenic Dyslipidemia
por: Frayn, Keith, et al.
Publicado: (2012)

Atherogenic Dyslipidemia and Cardiovascular Risk Factors in Obese Children
por: D'Adamo, Ebe, et al.
Publicado: (2015)

Hibernating brown bears are protected against atherogenic dyslipidemia
por: Giroud, Sylvain, et al.
Publicado: (2021)

Metabolic Overlap between Alzheimer’s Disease and Metabolic Syndrome Identifies the PVRL2 Gene as a New Modulator of Diabetic Dyslipidemia
por: Guardiola, Montse, et al.
Publicado: (2023)

Time of Progression to Osteopenia/Osteoporosis in Chronically HIV-Infected Patients: Screening DXA Scan
por: Negredo, Eugenia, et al.
Publicado: (2012)

Statistical mediation of the relationships between chronological age and lipoproteins by nonessential amino acids in healthy men
por: Mallol, Roger, et al.
Publicado: (2021)

Atherogenic dyslipidemia and diabetes mellitus: what’s new in the management arena?
por: Kumar, Ajoy, et al.
Publicado: (2010)

Atherogenic Dyslipidemia in Children: Evaluation of Clinical, Biochemical and Genetic Aspects
por: Montali, Anna, et al.
Publicado: (2015)

Atherogenic Dyslipidemia and Residual Vascular Risk in Practice of Family Doctor
por: Alibasic, Esad, et al.
Publicado: (2015)

Glycative Stress, Glycated Hemoglobin, and Atherogenic Dyslipidemia in Patients with Hyperlipidemia
por: Yao, Chien-An, et al.
Publicado: (2023)

Prevalence of dyslipidemia, atherogenic and cardiovascular risk in overweight and obese adolescents
por: de Andrades, Clara dos Santos, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_b47te14cjnvccks66ssfoon7oo